Microbot Medical® Announces FDA Submission for the Commercialization of the LIBERTY® Endovascular Robotic System
December 10, 2024 08:00 ET
|
Microbot Medical Inc.
FDA 510(k) Submission Follows the Successful Completion of the Pivotal Human Clinical Trial FDA 510(k) Clearance Anticipated During the Second Quarter of 2025 Company Preparing to Commence...
LogicMark, Inc. Announces Reverse Stock Splits
November 15, 2024 09:15 ET
|
LogicMark, Inc.
LOUISVILLE, Ky., Nov. 15, 2024 (GLOBE NEWSWIRE) -- LogicMark, Inc. (Nasdaq: LGMK) (the “Company”), a provider of personal emergency response systems (PERS), health communications devices, and...
Global Immunohistochemistry Market Size To Worth USD 4.84 Billion By 2033 | CAGR of 6.41%
June 18, 2024 14:00 ET
|
SPHERICAL INSIGHTS LLP
New York, United States , June 18, 2024 (GLOBE NEWSWIRE) -- The Global Immunohistochemistry Market Size is to Grow from USD 2.60 Billion in 2023 to USD 4.84 Billion by 2033, at a Compound Annual...
First in Minnesota: Park Nicollet Methodist Hospital Incorporates New State-of-the-Art Breast Cancer Treatment
April 13, 2023 09:00 ET
|
Elucent
SAINT LOUIS PARK, Minn., April 13, 2023 (GLOBE NEWSWIRE) -- Park Nicollet Methodist Hospital is the first in the state to use Elucent’s EnVisio™ Surgical Navigation System and SmartClip™ technology....